These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1724467)

  • 1. In vitro antiviral activity of a peptide-nucleic acid solution against the human immunodeficiency virus and influenza A virus.
    Friedland B
    J R Soc Health; 1991 Oct; 111(5):170-1. PubMed ID: 1724467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide nucleic acids stimulate gamma interferon and inhibit the replication of the human immunodeficiency virus.
    Hirschman SZ; Chen CW
    J Investig Med; 1996 Aug; 44(6):347-51. PubMed ID: 8795297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza.
    Wong JP; Christopher ME; Salazar AM; Sun LQ; Viswanathan S; Wang M; Saravolac EG; Cairns MJ
    Front Biosci (Schol Ed); 2010 Jan; 2(2):791-800. PubMed ID: 20036985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation.
    Lenard J; Rabson A; Vanderoef R
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):158-62. PubMed ID: 7678335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of influenza virus M1 zinc finger peptides.
    Nasser EH; Judd AK; Sanchez A; Anastasiou D; Bucher DJ
    J Virol; 1996 Dec; 70(12):8639-44. PubMed ID: 8970989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antiviral action of recombinant forms of the human T-lymphocyte CD4 receptor].
    Zverev VV; Maliushova VV; Sidorov AV; Pugach AV; Shukhmina NR; Pille ER; Mel'nikova NL; Andzhaparidze OG
    Vopr Virusol; 1994; 39(2):56-9. PubMed ID: 7517083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.
    Kucera LS; Iyer NP; Puckett SH; Buckheit RW; Westbrook L; Toyer BR; White EL; Germany-Decker JM; Shannon WM; Chen RC
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):307-14. PubMed ID: 7685612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
    Wild CT; Shugars DC; Greenwell TK; McDanal CB; Matthews TJ
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9770-4. PubMed ID: 7937889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to demonstrate antiviral activity of reticulose.
    KEMPE CH; FULGINITI VA; ST VINCENT L
    Am J Dis Child; 1962 May; 103():655-7. PubMed ID: 14455085
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of HIV replication by naphthalenemonosulfonic acid derivatives and a bis naphthalenedisulfonic acid compound.
    Mohan P; Singh R; Wepsiec J; Gonzalez I; Sun DK; Sarin PS
    Life Sci; 1990; 47(12):993-9. PubMed ID: 2122146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.
    Mohan P; Singh R; Baba M
    Drug Des Discov; 1991 Nov; 8(1):69-82. PubMed ID: 1725723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
    Wild C; Oas T; McDanal C; Bolognesi D; Matthews T
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10537-41. PubMed ID: 1438243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of fattiviracin FV-8 against human immunodeficiency virus type 1 (HIV-1).
    Habib ES; Yokomizo K; Nagao K; Harada S; Uyeda M
    Biosci Biotechnol Biochem; 2001 Mar; 65(3):683-5. PubMed ID: 11330690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of reticulose on viral infections of experimental animals.
    BEHBEHANI AM; HABERMAN S; RACE GJ
    South Med J; 1962 Feb; 55():185-8. PubMed ID: 13866577
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin.
    Momota K; Kaneko I; Kimura S; Mitamura K; Shimada K
    Biochem Biophys Res Commun; 1991 Aug; 179(1):243-50. PubMed ID: 1715691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of Ethiopian human immunodeficiency virus type 1 isolates to antiviral compounds.
    Wondimu Z; Sönnerborg A; Ayehunie S; Britton S; Strannegård O
    Antiviral Res; 1992 Oct; 19(4):353-9. PubMed ID: 1281393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine.
    Ojwang J; Elbaggari A; Marshall HB; Jayaraman K; McGrath MS; Rando RF
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):560-70. PubMed ID: 7513761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV.
    Hayashi K; Kamiya M; Hayashi T
    Planta Med; 1995 Jun; 61(3):237-41. PubMed ID: 7617766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of influenza A virus infection in vitro by peptides designed in silico.
    López-Martínez R; Ramírez-Salinas GL; Correa-Basurto J; Barrón BL
    PLoS One; 2013; 8(10):e76876. PubMed ID: 24146939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.